Related by context. All words. (Click for frequent words.) 80 prednisone VcMP 76 relapsed MM 75 mitoxantrone plus 75 plus prednisone 74 docetaxel chemotherapy 73 ACTEMRA TM 73 8mg/kg 73 abacavir lamivudine 73 dacarbazine 73 alfa 2a 73 melphalan prednisone 73 ribavirin RBV 73 PEGINTRON TM 72 Xeloda ® 72 tipranavir r 72 plus prednisone prednisolone 72 plus dexamethasone 72 gemcitabine carboplatin 72 FOLFIRI 71 TO AVOID PREGNANCY WHILE 71 relapsed refractory multiple myeloma 71 Peg IFN 71 certolizumab 71 dasatinib Sprycel ® 71 MAGE A3 ASCI 71 BARACLUDE ® 71 sorafenib tablets 71 relapsed multiple myeloma 71 Pegasys ® 71 gemcitabine cisplatin 71 erlotinib Tarceva ® 71 refractory chronic lymphocytic 71 EOquin TM 71 lopinavir r 71 placebo dexamethasone 71 PREZISTA r 71 untreated multiple myeloma 71 docetaxel Taxotere ® 71 salmeterol fluticasone 71 low dose cytarabine 70 vinorelbine 70 metastatic CRC 70 FUSILEV enhances 70 #mg BID [001] 70 Doxil ® 70 tenofovir emtricitabine 70 mRCC 70 chlorambucil 70 pegylated interferon alfa 2a 70 refractory NSCLC 70 metastatic renal cell carcinoma 70 biologic DMARD 70 5 FU leucovorin 70 lenalidomide Revlimid R 70 ribavirin therapy 70 pegylated liposomal doxorubicin 70 ritonavir boosted 70 plus gemcitabine 70 adalimumab Humira 70 alvespimycin 70 PEG IFN 70 boosted protease inhibitor 70 SPRYCEL ® 70 interferon alfa 2a 70 CIMZIA ™ 70 ULORIC 70 R# #mg BID 70 relapsing multiple sclerosis 70 AVONEX ® 70 evaluating tivozanib 70 FOLFOX4 70 vincristine doxorubicin 70 CTAP# Capsules 70 Xanafide 70 carboplatin paclitaxel 70 recurrent glioblastoma multiforme 70 APTIVUS r 69 DOXIL 69 leukemia AML 69 Tarceva TM 69 CIMZIA TM certolizumab pegol 69 Aptivus ® 69 dose dexamethasone 69 HBeAg seroconversion 69 sorafenib Nexavar 69 adriamycin 69 metastatic GIST 69 Navelbine ® 69 infliximab monotherapy 69 docetaxel Taxotere 69 administered subcutaneously 69 Aflibercept 69 ORENCIA ® 69 paclitaxel Taxol 69 CIMZIA TM 69 thalidomide Thalomid 69 mg QD 69 Pemetrexed 69 cisplatin gemcitabine 69 FEMALES SHOULD BE ADVISED 69 topical gel formulation 69 catheter occlusion 69 trastuzumab Herceptin R 69 cyclophosphamide methotrexate 69 peginterferon alfa 69 Gemzar ® 69 brand ciclesonide HFA 69 oxymorphone ER 69 Platinol ® cisplatin 69 CYT# potent vascular disrupting 69 dopamine partial agonist 69 #mg/m# [001] 69 dacarbazine DTIC 69 ancrod 69 decitabine 69 interferon ribavirin 69 TNF Tumor Necrosis Factor 69 PEGylated Fab fragment 69 mycophenolate mofetil 69 clodronate 69 PegIFN 68 subcutaneously administered 68 bendamustine 68 idarubicin 68 R sorafenib tablets 68 hyperphenylalaninemia HPA due 68 cell lymphoma CTCL 68 metastatic colorectal carcinoma 68 CANCIDAS 68 4mg/kg 68 everolimus eluting stents 68 biochemical relapse 68 cetuximab Erbitux R 68 bevacizumab Avastin ® 68 comparator arm 68 KRAS mutations occur 68 BRIM2 68 humanized interleukin 6 68 achieved ACR# 68 BENICAR 68 REVLIMID lenalidomide 68 alpha 2b 68 TELINTRA 68 pegylated interferon alpha 2a 68 PEGylated anti 68 Ophena TM 68 FASLODEX 68 recurrent NSCLC 68 alpha 2a 68 FOLFOX6 68 FOLFOX regimen 68 Telintra 68 basal bolus regimen 68 5 fluorouracil leucovorin 68 visilizumab 68 oral rivaroxaban 68 forodesine 68 5-FU/LV 68 telaprevir dosed 68 bone marrow reticulin deposition 68 neurologic progression 68 paclitaxel cisplatin 68 Cloretazine 68 mg qd 68 ug dose 68 recurrent GBM 68 azacitidine 68 receptor tyrosine kinase inhibitor 68 naïve HCV 68 Engerix B 68 ARIMIDEX 68 mcg QD 68 pegylated interferon alpha 68 refractory multiple myeloma 68 stage IIIb IV 68 rizatriptan 68 PEGASYS ® 68 #mg QD [002] 68 sunitinib Sutent ® 68 leukemia CLL 68 trabectedin 68 standard chemotherapy regimen 68 Pharmacokinetics PK 68 interferon gamma 1b 68 pegylated interferon alfa 68 dexamethasone Decadron 68 doxorubicin cyclophosphamide 68 fosamprenavir 68 immunomodulatory therapy 68 galiximab 68 oral ridaforolimus 68 elotuzumab 68 ® lenalidomide 68 chemoradiation therapy 68 Hazard Ratio 68 nilotinib Tasigna ® 68 FOLFIRI alone 68 metaglidasen 68 ZOLINZA 68 Daclizumab 68 herpetic keratitis 68 candesartan cilexetil 68 teriflunomide 68 plus DOXIL 68 lumiliximab 68 metastatic castration resistant 68 TAXOTERE R 68 weekly subcutaneous injections 67 adefovir dipivoxil 67 AVASTIN 67 mometasone furoate 67 BENICAR HCT 67 Hsp# Inhibitor 67 Folfox 67 LymphoStat B belimumab 67 potent CYP#A# inhibitors 67 generation purine nucleoside 67 posaconazole 67 Copegus ribavirin 67 Peginterferon alfa 2b 67 mg/m2 dose 67 Fludara 67 azathioprine 67 plus COPEGUS 67 dosage regimens 67 chemotherapy cisplatin 67 docetaxel Taxotere R 67 6 mercaptopurine 67 FOLFOX6 chemotherapy regimen 67 liposome injection 67 desvenlafaxine succinate 67 plus ribavirin 67 vidofludimus 67 severe neutropenia 67 CLARITY study 67 saline placebo 67 peginterferon alfa 2a Pegasys 67 paclitaxel Taxol ® 67 q#h 67 CIMZIA R 67 GW# [003] 67 CCX# B 67 anthracycline taxane 67 assessing T DM1 67 mg BID 67 huN# DM1 67 interferon beta 1a 67 mg/m2/day 67 ritonavir boosted atazanavir 67 goserelin 67 PEG interferon 67 receiving prophylactic anticoagulation 67 Teriflunomide 67 prednisone prednisolone plus 67 GAMMAGARD 67 Albuferon TM 67 concurrent chemoradiation 67 metastatic hormone refractory 67 pioglitazone HCl 67 REMINYL ® 67 malignancy HCM 67 PSMA ADC 67 stage IIIB 67 nab paclitaxel 67 morphometric vertebral fractures 67 Elitek 67 COPEGUS ribavirin 67 novel VDA molecule 67 Peginterferon 67 unresectable locally advanced 67 somatostatin analog 67 #mg BID [003] 67 pharmacodynamic properties 67 serum phosphorous 67 voriconazole 67 crizotinib PF # 67 hyperplasia BPH 67 INCB# [003] 67 doxorubicin HCl liposome injection 67 venlafaxine XR 67 refractory AML 67 miconazole Lauriad ® 67 gefitinib Iressa 67 DEB# 67 alkylating agent 67 ribavirin Copegus ® 67 ORENCIA R 67 Amrubicin 67 gemcitabine Gemzar ® 67 interferon alfa 2b 67 fluoropyrimidine 67 induced macular edema 67 VcMP 67 R rilonacept Injection 67 prostate cancer HRPC 67 daunorubicin 67 mg m² 67 Free Survival PFS 67 Pegasys peginterferon alfa 2a 67 MabCampath 67 Hycamtin ® 67 progression TTP 67 AGILECT R 67 mg kg dose 67 cisplatin vinorelbine 67 Flu Cy 67 paclitaxel eluting stents 67 COPEGUS R 67 Phase Ib clinical 67 mycophenolic acid 67 TELCYTA 67 gemcitabine Gemzar 67 reduce serum phosphate 67 receiving INTRON 67 recurrent glioblastoma 67 sunitinib malate 67 REMICADE ® 67 recurrent genital herpes 67 atazanavir ritonavir 67 oxycodone CR 67 HES CEL 67 CALGB # [002] 67 oral prodrug 67 cyclophosphamide vincristine 67 imatinib Gleevec ® 67 demonstrated antitumor activity 67 oral antidiabetic medication 67 CHOP chemotherapy 67 nicardipine 67 irbesartan 67 reteplase 67 EDEMA3 67 nadolol 67 plus OBT 67 fluorouracil 66 mcg BID 66 estramustine 66 relapsed myeloma 66 bortezomib Velcade R 66 pyrazinamide 66 autoantibody positive 66 ceftazidime 66 Ceplene/IL-2 66 paclitaxel carboplatin 66 refractory CLL 66 peginterferon alfa 2a 66 intravesical infusion therapy 66 RoACTEMRA 66 Pegasys plus Copegus 66 IFN α 66 Zorbtive TM 66 FIRMAGON 66 non splenectomized 66 6R BH4 66 PULMICORT RESPULES 66 amoxicillin clavulanate 66 metastatic malignant 66 doxorubicin docetaxel 66 oropharyngeal candidiasis OPC 66 Perforomist Inhalation Solution 66 Panzem R NCD 66 μg dose 66 ara C 66 calcineurin inhibitor 66 peginterferon alfa 2b 66 beta2 agonist 66 volociximab 66 azilsartan medoxomil 66 Median PFS 66 basiliximab 66 HBeAg negative patients 66 protease inhibitor PI 66 DAPT 66 Lenalidomide 66 Seliciclib 66 FluCAM 66 unfractionated heparin UFH 66 peg IFN 66 tumors GIST 66 Bezielle 66 mCRC patients 66 mitomycin 66 diagnosed multiple myeloma 66 axitinib 66 oral talactoferrin 66 nucleoside analog 66 denileukin diftitox 66 MACUGEN 66 R lenalidomide 66 mcg albinterferon alfa 2b 66 neutropenia dehydration dyspnea 66 dasatinib Sprycel 66 lispro 66 ergot derivatives 66 metformin sulfonylurea 66 beta 1a 66 Mg Uk 66 COMBIVIR 66 #mg/m# [002] 66 custirsen 66 Paraplatin ® 66 HER2 positive metastatic breast 66 beclomethasone dipropionate 66 Gliadel Wafer 66 myelodysplastic myeloproliferative diseases 66 zonisamide SR 66 EURIDIS 66 postmenopausal osteoporotic women 66 IFN beta 66 Cleviprex TM clevidipine 66 verteporfin 66 divalproex sodium 66 YONDELIS 66 Aclidinium 66 mcg kg 66 baminercept 66 fluticasone salmeterol 66 Vidaza ® 66 Femara letrozole 66 liposomal doxorubicin 66 conventional DMARDs 66 interferon beta 1a infertility 66 ALVESCO ® 66 huC# DM4 66 adjunctive placebo 66 dacetuzumab 66 ARIXTRA 66 rapid virologic response 66 peginterferon alpha 2a 66 receiving VELCADE 66 lopinavir ritonavir Kaletra 66 Certolizumab 66 COPEGUS 66 previously untreated follicular 66 cyclophosphamide chemotherapy 66 ARCALYST ® 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 HBeAg positive patients 66 TORISEL 66 EGFR TKI 66 Irinotecan 66 LPV r 66 PROMACTA 66 cilengitide 66 AAG geldanamycin analog 66 pegylated alpha interferon 66 LEUKINE 66 TAXUS Express Stent 66 Interferon beta 1a 66 octreotide LAR 66 INSPIRE Trial Phase III 66 lopinavir r arm 66 refractory gout 66 pegylated interferons 66 retinal vein occlusion induced 66 FAMPYRA 66 cetuximab Erbitux ® 66 lintuzumab SGN 66 #mg doses [002] 66 FOLPI 66 rFSH 66 XIENCE V PROMUS Stent 66 mg administered orally 66 adenosine injection 66 Cloretazine R VNP#M 66 ® bortezomib 66 TTF Therapy 66 MIRAPEX 66 Natalizumab 66 relapsing remitting MS RRMS 66 esophageal candidiasis 66 diarrhea predominant irritable 66 PegIFN RBV 66 endoscopic remission 66 Omacetaxine 66 BROVANA 66 advanced hepatocellular carcinoma 66 oral FTY# 66 colesevelam HCl 66 treatment naive genotype 66 cisplatin chemotherapy 66 pertuzumab 66 cyclophosphamide doxorubicin vincristine 66 timolol 66 Vidaza azacitidine 66 Plicera 66 Omacetaxine mepesuccinate 66 modified glutathione analog 66 HBeAg negative 66 relapsed SCLC 66 Ovitrelle R Serostim 66 bortezomib refractory 66 TLK# 66 Ixempra 66 prednisone prednisolone 66 refractory acute myeloid 66 BARACLUDE R 66 omega interferon 66 Taxol ® 66 deep venous thromboses 66 cyclophosphamide FC 65 temsirolimus 65 fluticasone propionate 65 oral chemotherapeutic agent 65 liposomal formulation 65 #.#g/day 65 partial remissions 65 ug kg 65 PROCTOCORT R 65 Aeroquin 65 gemcitabine chemotherapy 65 abacavir Ziagen 65 IMiDs ® 65 mapatumumab 65 alpha interferons 65 remission induction 65 sargramostim 65 TYGACIL 65 pegylated interferon alfa 2b 65 HBeAg + 65 genotypic resistance 65 evaluating REVLIMID 65 Traficet EN 65 Copegus ® 65 oral beclomethasone dipropionate 65 iobenguane 65 DAS# remission 65 Zevalin R Ibritumomab 65 refractory metastatic colorectal cancer 65 splenectomized 65 subcutaneous enoxaparin 65 FOLFIRI chemotherapy 65 BUPHENYL R sodium phenylbutyrate 65 Fludarabine 65 pomalidomide 65 potent triglyceride lowering 65 letrozole Femara 65 R Saizen R 65 TYKERB 65 Newly Diagnosed Multiple Myeloma 65 Phase IIIb clinical 65 docetaxel prednisone 65 non metastatic osteosarcoma 65 Alkeran 65 vinorelbine tartrate 65 HIV coinfected 65 Pegylated Liposomal Doxorubicin 65 fallopian tube carcinoma 65 lanthanum carbonate 65 somatostatin analogue 65 dose cytarabine 65 sunitinib Sutent 65 HCV RESPOND 2 65 antiarrhythmic drug 65 #mg/day [001] 65 vinca alkaloid 65 FOLFOX 65 microbiological eradication 65 Tarceva erlotinib 65 aspirin clopidogrel 65 adecatumumab 65 Mg Usa 65 glufosfamide 65 #mg/#mg 65 adjuvant cisplatin 65 PASI scores 65 piperacillin tazobactam 65 Infusion Reactions Severe 65 histone deacetylase HDAC inhibitor 65 rosuvastatin #mg 65 5 Fluorouracil 65 TNF antagonist 65 virus HCV protease inhibitor 65 LymphoStat B TM 65 SCIg 65 Phase #b/#a clinical 65 lapatinib Tykerb 65 selective modulator 65 #mg ATC 65 Taxotere ® 65 octreotide acetate 65 BUPHENYL 65 lamivudine refractory patients 65 PKC# 65 Oral NKTR 65 nilotinib 65 KRN# 65 NMIBC 65 tapentadol ER 65 AMEVIVE 65 systemic anaplastic large 65 liposomal amphotericin B 65 refractory cutaneous T 65 INVEGA ® 65 insulin glulisine 65 ZACTIMA 65 PSA nadir 65 amprenavir 65 annualized relapse 65 amrubicin 65 anthracyclines taxanes 65 PNP inhibitor 65 pegylated IFN 65 unresectable tumors 65 EPIVIR 65 tenofovir disoproxil fumarate Viread 65 FROVA 65 ONTAK 65 ISTODAX ® 65 primary hypercholesterolemia 65 viral kinetics 65 clomipramine 65 Fludara ® 65 ZYVOX 65 q8h 65 ONGLYZA saxagliptin 65 EGFR expressing mCRC 65 Dacogen injection 65 AQ4N 65 RECORD1 65 oral diclofenac 65 leukotriene receptor antagonist 65 mcg kg REBETOL 65 5-fluorouracil/leucovorin 65 Cimzia TM 65 PRISTIQ 65 Platinol ® 65 Temodar ® 65 marketed pegylated interferons 65 tigecycline 65 bevacizumab Avastin R 65 CD3 monoclonal antibody 65 3mg/kg 65 virologic failure 65 Mitoxantrone 65 dextromethorphan quinidine 65 Meets Primary Endpoint 65 MGd 65 oral vancomycin 65 lenalidomide dexamethasone 65 CorVue ™ 65 Durezol 65 IMiDs 65 radiation sensitizer 65 IV Busulfex 65 peginterferon alfa 2a #KD 65 ELACYT 65 Decitabine 65 EZN 65 -#.# log# copies mL 65 mucosal healing 65 log# IU mL 65 Phase Ib study 65 CAELYX 65 dalteparin 65 oblimersen 65 IFN alfa 65 chemotherapy docetaxel 65 Inhalation Aerosol 65 ATACAND 65 Thal Dex 65 RRMS patients 65 Lantus ® 65 APTIVUS 65 SNT-MC#/idebenone 65 metastatic RCC 65 MyVax R 65 RhuDex ® 65 HGS ETR1 mapatumumab 65 Fibrillex TM 65 formoterol fumarate 65 oral allopurinol 65 Perforomist ™ Inhalation Solution 65 pamidronate 65 NATRECOR R 65 intravenous bolus 65 IXEMPRA 65 trans retinoic acid ATRA 65 NATRECOR ® 65 IMiDs ® compound 65 Leukine ® 65 golimumab CNTO 65 Orally administered 65 advanced metastatic renal 65 INTEGRILIN ® 65 briakinumab 65 non nucleoside inhibitor 65 insulin glargine rDNA origin 65 Targretin capsules 65 Relapsed Refractory Multiple Myeloma 65 complete cytogenetic response 65 plus methotrexate 65 novel emulsion formulation 65 vapreotide acetate 65 Acetate Rectal Suppositories 65 caspofungin 65 O PPDS 65 NPH insulin 65 carboplatin chemotherapy 65 EGFR mutation positive 65 Oral Fingolimod 65 multicenter Phase III 65 unresectable HCC 65 Known hypersensitivity 65 Investigational Oral 65 Capesaris 65 equi analgesic doses 65 antibody MAb 65 nonmetastatic 65 adalimumab 65 Torisel 65 PEG SN# 65 ritonavir boosted lopinavir 65 EFFEXOR XR 65 bexarotene 65 inhaled iloprost 65 cangrelor 65 ALVESCO R 65 lanreotide 65 lexidronam injection 65 ProSavin 65 median PFS 65 VEGFR2 inhibitor 65 recurrent metastatic 65 unique alkylating agent 65 emtricitabine tenofovir 65 essential thrombocythemia ET 65 IV NSCLC 65 INC# 64 DAVANAT 64 tamoxifen Nolvadex ® 64 PEGylated interferon beta 1a 64 paclitaxel Taxol R 64 BCG refractory carcinoma 64 cytarabine daunorubicin 64 efavirenz EFV 64 infliximab 64 MIRCERA 64 unresectable stage 64 ABILIFY ® 64 dosing cohort 64 fluvastatin 64 atorvastatin #mg 64 pyrexia mucositis sepsis febrile 64 Sandostatin R 64 HMG CoA reductase inhibitors 64 macrolide antibiotic 64 Certolizumab pegol 64 bupropion SR 64 TAXUS Liberte Long 64 INCB# [001] 64 lumbar spine BMD 64 RLAI 64 5 fluorouracil 64 GOUT 64 gemtuzumab ozogamicin 64 Cariprazine 64 Keppra XR 64 OMS# 64 sirolimus eluting stents 64 Inhalation Solution 64 Trastuzumab 64 postoperative chemotherapy 64 XELOX 64 placebo controlled clinical 64 Safinamide 64 ertapenem 64 tanespimycin 64 Contrave# 64 #.#mg/dL 64 non squamous NSCLC 64 noninferior 64 orally inhaled migraine 64 budesonide pMDI 64 mitoxantrone 64 castrate resistant prostate cancer 64 DexaSite 64 low dose Iluvien 64 LEXIVA r 64 donepezil Aricept 64 intravesical instillation 64 rituximab refractory 64 lintuzumab 64 receiving PEGINTRON 64 neratinib 64 pegfilgrastim 64 hormone refractory metastatic prostate 64 pCR 64 phase IIb clinical 64 Topotecan 64 lenalidomide Revlimid ® 64 Temsirolimus 64 pemetrexed 64 IN PATIENTS WITH 64 REYATAZ r 64 highly emetogenic 64 GSK# [001] 64 de novo kidney transplant 64 fludarabine phosphate 64 corticosteroid dose 64 HGS# 64 CIPN 64 temsirolimus Torisel ® 64 novel histone deacetylase 64 HuMax EGFr 64 Quinamed 64 arsenic trioxide injection 64 invasive candidiasis 64 refractory CTCL 64 blinded randomized placebo controlled 64 mecasermin 64 novel topoisomerase 64 CLL SLL 64 flutamide 64 metastatic colorectal 64 Tocilizumab 64 refractory follicular lymphoma 64 SVR# 64 Adjunctive 64 Romidepsin 64 Alocrest 64 FOLOTYN ® 64 pan HDAC inhibitor 64 ARB telmisartan 64 2 methoxyestradiol 64 abatacept 64 delivers fluocinolone acetonide FA 64 registrational Phase 64 doxazosin 64 intranasal formulation 64 monotherapy 64 efalizumab 64 tumor xenograft models 64 subcutaneous formulation 64 acyclovir Lauriad R 64 randomized #:#:# 64 mcg dose 64 Sanofi Aventis Taxotere 64 pharmacokinetic equivalence 64 etanercept Enbrel 64 TKM ApoB 64 Amgen Neulasta R 64 aflibercept VEGF Trap 64 terfenadine 64 trimethoprim sulfamethoxazole 64 Simulect 64 recurrent malignant glioma 64 IV bolus 64 NOXAFIL Oral Suspension 64 Aloxi injection 64 sapropterin dihydrochloride Tablets 64 Patients Treated With 64 irinotecan chemotherapy 64 trastuzumab Herceptin ® 64 APTIVUS R 64 uremic pruritus 64 DU #b 64 mg kg BID 64 anagrelide 64 HERCEPTIN 64 Hormone Refractory Prostate Cancer 64 opioid induced bowel dysfunction 64 metastatic HRPC 64 Virulizin ® 64 SYNERGY Stent 64 non valvular atrial 64 Raptiva ® 64 tolterodine ER 64 #mg q8h 64 vandetanib 64 Adalimumab 64 Halaven 64 tenofovir disoproxil fumarate 64 docetaxel Injection Concentrate 64 hematological parameters 64 neoadjuvant 64 prospectively stratified 64 Tavocept 64 ularitide 64 fallopian tube cancers 64 Phase 1a clinical 64 active comparator 64 Aztreonam lysine 64 Navelbine 64 mg q#h 64 5mg/kg 64 PD LID 64 Cloretazine ® 64 imipenem 64 BCG refractory 64 reslizumab 64 Androxal TM 64 mg/# hr 64 urinary N telopeptide 64 toenail onychomycosis 64 relapsed acute myelogenous 64 achieved CCyR 64 FluCAM arm 64 CR nPR 64 imetelstat 64 Gel repository corticotropin injection 64 irinotecan cisplatin 64 ILUVIEN ® 64 ACR# ACR# 64 clopidogrel Plavix 64 cutaneous T 64 5FU 64 systemically administered 64 HGS ETR2 64 severe exacerbations 64 Ribavirin causes 64 tinidazole 64 idraparinux 64 evaluable subjects 64 free survival PFS 64 AKT inhibitor 64 CsA 64 pharmacokinetics PK 64 Voreloxin 64 glycoprotein IIb IIIa inhibitor 64 interferon beta 1b 64 plus MTX 64 indinavir Crixivan 64 #mg QD [001] 64 subcutaneous SC 64 dose cohort 64 tacrolimus ointment 64 rFIXFc 64 Elagolix 64 Interferon beta 64 mGluR5 NAM 64 capecitabine Xeloda 64 LUCENTIS 64 multiple myeloma MM 64 prokinetic agent 64 ARCOXIA 64 RAPAFLO R 64 urate lowering 64 xanthine oxidase inhibitor 64 hypereosinophilic syndrome 64 pain palliation 64 TPV r 64 serum phosphorus 64 dirucotide MBP# 64 brivaracetam 64 OncoVEX GM CSF 64 Diffuse Large B 64 #mg dose [003] 64 CHAMPION PCI 64 REVIVE Diabetes 64 Emtriva Viread 64 Interferon beta 1b 64 Erlotinib 64 Glufosfamide 64 PI3K/Akt pathway inhibitor 64 Jevtana 64 MYDICAR ® 64 serologically active systemic lupus 64 ALA PDT 64 ADP receptor antagonist 64 salmeterol inhalation powder 64 refractory indolent non 64 LCP Tacro 64 KRAS mutant tumors 64 Clolar ® 64 binary restenosis 64 Kepivance 64 PRT# 64 orally administered inhibitor 64 incidence ≥ 64 Atripla combines 64 Bortezomib 64 Annamycin 64 Proellex TM 64 PROCTOCORT ® Suppository Hydrocortisone 64 Xelox 64 STELARA 64 atrial fibrillation budiodarone ATI 64 peripherally acting 64 PAOD 64 ethambutol 64 dyskinesia PD LID 64 DDP# 64 AZT zidovudine Retrovir 64 QD dosing 64 Betaferon R 64 β blockers 64 anastrazole 64 Linagliptin 64 PROVENGE ® 64 Pimavanserin 64 dosing cohorts 64 hormone LHRH antagonist 64 fulvestrant 64 epirubicin cyclophosphamide 64 Taxotere R 64 mg TID 64 mitoxantrone chemotherapy 64 MoxDuo TM IR